Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells have been recently described to localize to breast carcinomas, where they integrate into the tumour-associated stroma. However, the involvement of mesenchymal stem cells (or their derivatives) in tumour pathophysiology has not been addressed. Here, we demonstrate that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft. The breast cancer cells stimulate de novo secretion of the chemokine CCL5 (also called RANTES) from mesenchymal stem cells, which then acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis. This enhanced metastatic ability is reversible and is dependent on CCL5 signalling through the chemokine receptor CCR5. Collectively, these data demonstrate that the tumour microenvironment facilitates metastatic spread by eliciting reversible changes in the phenotype of cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MSC can be mobilized and recruited to active tumor sites, where they can incorporate into the tumor’s microenvironment [5, 68, 100–103].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“CCL5 can be secreted by both BM-MSC and ASC [100, 144] and displays pro-proliferative activities on breast cancer cell lines [145, 146].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“Another MSC-secreted pro-metastasis cytokine, CCL5 (RANTES), can be secreted upon interaction with cancer cells and is associated with tumor progression and invasion in various cancers [73, 87, 100, 142–144].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [100]
In the citing paper
“The injection of bone marrow-derived MSCs into tumour-bearing mice has demonstrated that they can become CAFs40”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [40]
In the citing paper
“CAFs comprise the majority of cell types within the TME, and their reciprocal interactions with cancer cells have been well documented (Whiteside, 2008; Hazlehurst et al., 2003; Karnoub et al., 2007).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Karnoub et al., 2007
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Self-citationCreation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Self-citationHuman Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
(2002) · PubMed · Cited by 903
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
Elenbaas, B., Spirio, L., Koerner, F., Fleming, M. D., Zimonjic, D. B., Donaher, J. L., Popescu, N. C., Hahn, W. C., & Weinberg, R. A. (2001) · Genes & Development · doi:10.1101/gad.828901 · Cited by 878
Self-citationX chromosomal abnormalities in basal-like human breast cancer
Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.013 · Cited by 869
Self-citationReconstruction of functionally normal and malignant human breast tissues in mice
Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J. W., Carey, L., Richardson, A., & Weinberg, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401064101 · Cited by 804
Self-citationHuman mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Qin, X.-F., An, D. S., Chen, I. S. Y., & Baltimore, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232688199 · Cited by 701
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y., & Hamada, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302276 · Cited by 597
Young, H. E., Steele, T. A., Bray, R. A., Hudson, J., Floyd, J. A., Hawkins, K., Thomas, K., Austin, T., Edwards, C., Cuzzourt, J., et al. (2001) · The Anatomical Record · doi:10.1002/ar.1128 · Cited by 545
The influence of the microenvironment on the malignant phenotype
Park, C. C., Bissell, M. J., & Barcellos-Hoff, M. H. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01756-1 · Cited by 398
Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., & Ben‐Baruch, A. (2002) · PubMed · Cited by 371
Luboshits, G., Shina, S., Kaplan, O., Engelberg, S., Nass, D., Lifshitz-Mercer, B., Chaitchik, S., Keydar, I., & Ben‐Baruch, A. (1999) · PubMed · Cited by 350
Recent advances into the understanding of mesenchymal stem cell trafficking
Fox, J. M., Chamberlain, G., Ashton, B. A., & Middleton, J. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06610.x · Cited by 303
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
Komarova, S., Kawakami, Y., Stoff-Khalili, M. A., Curiel, D. T., & Pereboeva, L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0334 · Cited by 302
Akt Signaling and Cancer: Surviving but not Moving On
Toker, A., & Yoeli-Lerner, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0743 · Cited by 295
A chemokine receptor antagonist inhibits experimental breast tumor growth.
Robinson, S. C., Scott, K. A., Wilson, J. L., Thompson, R. G., Proudfoot, A. E. I., & Balkwill, F. R. (2003) · PubMed · Cited by 287
Non-hematopoietic bone marrow stem cells: Molecular control of expansion and differentiation
Gregory, C. A., Prockop, D. J., & Spees, J. L. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.03.018 · Cited by 270
Hung, S.-C., Deng, W.-P., Yang, W. K., Liu, R.-S., Lee, C.-C., Su, T.-C., Lin, R.-J., Yang, D.-M., Chang, C.-W., Chen, W.-H., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0876 · Cited by 268
Niwa, Y., Akamatsu, H., Niwa, H., Sumi, H., Ozaki, Y., & Abe, A. (2001) · PubMed · Cited by 245
Menon, L. G., Picinich, S., Koneru, R., Gao, H., Lin, S. Y., Koneru, M., Mayer-Kuckuk, P., Glod, J., & Banerjee, D. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0257 · Cited by 237
Hall, B., Andreeff, M., & Marini, F. (2007) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-68976-8_12 · Cited by 194
Determination of Stromal Signatures in Breast Carcinoma
West, R. B., Nuyten, D. S. A., Subramanian, S., Nielsen, T. O., Corless, C. L., Rubin, B. P., Montgomery, K., Zhu, S., Patel, R., Hernandez-Boussard, T., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030187 · Cited by 194
Chemokines in tumor progression and metastasis
Tanaka, T., Bai, Z., Srinoulprasert, Y., Yang, B., Hayasaka, H., & Miyasaka, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00059.x · Cited by 192
Lodie, T. A., Blickarz, C. E., Devarakonda, T. J., He, C., Dash, A. B., Clarke, J., Gleneck, K., Shihabuddin, L., & Tubo, R. (2002) · Tissue Engineering · doi:10.1089/10763270260424105 · Cited by 133
Self-citationChemokine Networks and Breast Cancer Metastasis
Karnoub, A. E., & Weinberg, R. A. (2007) · Breast Disease · doi:10.3233/bd-2007-26107 · Cited by 130
Self-citationYoung, W., Duplàa, C., Young, T. M., Floyd, J. A., Reeves, M. L., Davis, K. H., Mancini, G. J., Eaton, M. E., Hill, J. D., Thomas, K. S. C., et al. (2001) · The Anatomical Record · doi:10.1002/ar.1112 · Cited by 87
A role for chemokine receptor transactivation in growth factor signaling
Mira, E., Lacalle, R. A., González, M. A., Gómez‐Moutón, C., Abad, J. L., Bernad, A., Martínez‐A, C., & Mañes, S. (2001) · EMBO reports · doi:10.1093/embo-reports/kve027 · Cited by 86
Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists
Palani, A., & Tagat, J. R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060009x · Cited by 85
Expression of chemokines on the surface of different human endothelia
Hillyer, P., & Male, D. (2005) · Immunology & Cell Biology · doi:10.1111/j.1440-1711.2005.01345.x · Cited by 38
Cited by
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
“For example, mesenchymal stem cells (MSCs) present in the tumor stroma have been found to secrete CCL5/RANTES in response to signals released by cancer cells; CCL5 then acts reciprocally on the cancer cells to stimulate invasive behavior (Karnoub et al., 2007).”
Self-citationEpithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
“A subpopulation of cancer-associated fibroblasts, the bone marrow-derived activated mesenchymal stem cells that are present in tumor stroma, instruct cancer cells in the primary tumor, enhancing their metastatic ability by promoting migration and extravasation (Figure 6B) (Karnoub et al., 2007).”
BackgroundAccessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
“…cancer cells, thereby enabling their capability for invasion and metastasis (Chaffer and Weinberg , 2011); likely additional CAF mediators will prove to be involved in different contexts; thus, for example, CAF/MSC secretion of CCL5 stimulates breast cancer metastasis (Karnoub et al., 2007).”
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863
Metadata
- Authors
- Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Weinberg, Robert A.
- Venue
- Nature
- Published
- 2007-10-04
- Volume
- 449
- Issue
- 7162
- Pages
- 557-563
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2141815918
- Cited by
- 3,206
- References
- 36
- Citations by year
- 2026: 41 · 2025: 69 · 2024: 95 · 2023: 137 · 2022: 144 · 2021: 186 · 2020: 192 · 2019: 153 · 2018: 145 · 2017: 176 · 2016: 182 · 2015: 222 · 2014: 232 · 2013: 232 · 2012: 216
- FWCI
- 89.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Cancer Institute (P50CA089393, R01CA116235)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Keywords
- mesenchymal stem cells, breast cancer metastasis, tumor stroma, RANTES, CCR5, paracrine signaling, tumor cell motility, tumor invasion, tumor microenvironment, bone marrow-derived stem cells, tumor xenografts
- MeSH terms
- Animals, Breast Neoplasms, Cell Movement, Fibroblasts, Humans, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasm Transplantation, Mice, SCID, Mice, Inbred NOD, Stromal Cells, Carcinoma, Ductal, Breast, Chemokine CCL5, Receptors, CCR5, Chemokines, CC, Paracrine Communication, Mesenchymal Stem Cell Transplantation, Cell Line, Tumor, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.